Georges Delsol

Toulouse, France

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 11 publications

Prevalence of CD30 immunostaining in neoplastic mast cells: A retrospective immunohistochemical study.

Prevalence of CD30 immunostaining in neoplastic mast cells: A retrospective immunohistochemical study.

Journal: Medicine

Published: May 26, 2018

Breast implant-associated anaplastic large cell lymphoma: two distinct clinicopathological variants with different outcomes.

Breast implant-associated anaplastic large cell lymphoma: two distinct clinicopathological variants with different outcomes.

Journal: Annals of oncology : official journal of the European Society for Medical Oncology

Published: September 25, 2015

Angioimmunoblastic T-cell lymphoma is the most common T-cell lymphoma in two distinct French information data sets.

Angioimmunoblastic T-cell lymphoma is the most common T-cell lymphoma in two distinct French information data sets.

Journal: Haematologica

Published: June 06, 2015

Clinical analysis and prognostic significance of haemophagocytic lymphohistiocytosis-associated anaplastic large cell lymphoma in children.

Clinical analysis and prognostic significance of haemophagocytic lymphohistiocytosis-associated anaplastic large cell lymphoma in children.

Journal: British journal of haematology

Published: August 04, 2013

CD30-positive peripheral T-cell lymphomas share molecular and phenotypic features.

CD30-positive peripheral T-cell lymphomas share molecular and phenotypic features.

Journal: Haematologica

Published: May 30, 2013

Long-term outcome of adults with systemic anaplastic large-cell lymphoma treated within the Groupe d'Etude des Lymphomes de l'Adulte trials.

Long-term outcome of adults with systemic anaplastic large-cell lymphoma treated within the Groupe d'Etude des Lymphomes de l'Adulte trials.

Journal: Journal of clinical oncology : official journal of the American Society of Clinical Oncology

Published: October 10, 2012

Anaplastic lymphoma kinase as a therapeutic target.

Anaplastic lymphoma kinase as a therapeutic target.

Journal: Expert opinion on therapeutic targets

Published: September 25, 2012

A 4-weekly course of rituximab is safe and improves tumor control for patients with minimal residual disease persisting 3 months after autologous hematopoietic stem-cell transplantation: results of a prospective multicenter phase II study in patients with follicular lymphoma.

A 4-weekly course of rituximab is safe and improves tumor control for patients with minimal residual disease persisting 3 months after autologous hematopoietic stem-cell transplantation: results of a prospective multicenter phase II study in patients with follicular lymphoma.

Journal: Annals of oncology : official journal of the European Society for Medical Oncology

Published: July 07, 2012

ALK+ALCLs induce cutaneous, HMGB-1-dependent IL-8/CXCL8 production by keratinocytes through NF-κB activation.

ALK+ALCLs induce cutaneous, HMGB-1-dependent IL-8/CXCL8 production by keratinocytes through NF-κB activation.

Journal: Blood

Published: March 08, 2012

Technical note: Hapten synthesis, antibody production and development of an enzyme-linked immunosorbent assay for detection of the natural steroidal alkaloid Dendrogenin A.

Technical note: Hapten synthesis, antibody production and development of an enzyme-linked immunosorbent assay for detection of the natural steroidal alkaloid Dendrogenin A.

Journal: Biochimie

Published: January 13, 2012

Prognostic impact of morphologic and phenotypic features of childhood ALK-positive anaplastic large-cell lymphoma: results of the ALCL99 study.

Prognostic impact of morphologic and phenotypic features of childhood ALK-positive anaplastic large-cell lymphoma: results of the ALCL99 study.

Journal: Journal of clinical oncology : official journal of the American Society of Clinical Oncology

Published: November 16, 2011

Showing 1-11 of 11

Last Updated: 09/26/2026